Good acceptability of HIV, HBV, and HCV screening during immigration medical check-up amongst migrants in France in the STRADA study.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 17 12 2019
accepted: 11 06 2020
entrez: 27 6 2020
pubmed: 27 6 2020
medline: 5 9 2020
Statut: epublish

Résumé

The prevalence of HIV, hepatitis B, and hepatitis C amongst migrants in France is high. Thus, effective screening and follow-up is needed. The mandatory medical check-up for residency application is an opportunity to offer rapid HIV and hepatitis testing. The main objective of the STRADA study is to create a feasible and acceptable screening strategy for migrants. Within the STRADA study, this qualitative research examined the acceptability of conducting screening tests in the context of residency application. We conducted a qualitative study amongst legal migrants over 18 years of age with sufficient knowledge of the French, English, or Arabic language. Interviews were performed following a semi-structured interview guide of open-ended questions. Interviews were transcribed verbatim and subsequently analyzed through thematic analysis. We interviewed 34 migrants. Mean age was 32.6 (min-max: 19, 59) years. The participants' region of origin was mostly Sub-Saharan Africa and the main reason for migrating to France was family reunification. Migrants' acceptability of HIV and hepatitis testing was high. Participants who accepted testing indicated a benefit for individual health and to avoid transmission. Most preferred rapid tests; reluctance was related to anxiety about the immediate results and the perceived reliability of rapid tests. Migrants' knowledge about HIV was satisfactory, but inadequate for hepatitis. Screening in the context of a compulsory medical visit did not present an obstacle for acceptability. Some expressed concern in the case of HIV but when explained, the independence between obtaining the residence permit along with screening and access to medical care was well understood. Medical check-ups at immigration centers is an opportunity to screen for HIV and hepatitis which is considered acceptable by migrants. Informing migrants that test results do not affect residency applications, and incorporating their preferences, are all important to optimize the acceptability of screening.

Identifiants

pubmed: 32589652
doi: 10.1371/journal.pone.0235260
pii: PONE-D-19-34902
pmc: PMC7319329
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0235260

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

BMC Health Serv Res. 2016 Jan 15;16:14
pubmed: 26772613
BMJ Open. 2012 Apr 01;2(2):e000693
pubmed: 22466158
J Int AIDS Soc. 2015 Nov 18;18:20317
pubmed: 26584954
J Med Virol. 2010 Apr;82(4):546-55
pubmed: 20166185
BMC Public Health. 2013 Jun 13;13:576
pubmed: 23764171
Lancet. 2019 Jun 15;393(10189):2428-2438
pubmed: 31056293
Med Mal Infect. 2012 Nov;42(11):553-60
pubmed: 23026269
Euro Surveill. 2018 Mar;23(10):
pubmed: 29536830
Intern Med J. 2012 May;42(5):497-504
pubmed: 21299780
Swiss Med Wkly. 2011 Mar 08;141:w13178
pubmed: 21384286
Health Qual Life Outcomes. 2006 Oct 11;4:79
pubmed: 17034633
Can J Gastroenterol Hepatol. 2015 Nov-Dec;29(8):411-6
pubmed: 26492129
AIDS Care. 2015;27(4):499-506
pubmed: 25428563
BMC Public Health. 2015 Feb 15;15:151
pubmed: 25886390
Infection. 2016 Apr;44(2):151-8
pubmed: 26471511
Eur J Public Health. 2016 Jun;26(3):389-95
pubmed: 26896472
AIDS Educ Prev. 2012 Oct;24(5):456-68
pubmed: 23016506
Eur J Public Health. 2013 Dec;23(6):1039-45
pubmed: 23002238
Eur J Gen Pract. 2018 Dec;24(1):60-67
pubmed: 29172800
Euro Surveill. 2018 Mar;23(11):
pubmed: 29560855
PLoS One. 2016 Feb 25;11(2):e0150223
pubmed: 26914023
AIDS Behav. 2015 Nov;19(11):2012-24
pubmed: 26025193
Sex Transm Infect. 2020 May;96(3):227-231
pubmed: 31350379
BMC Public Health. 2009 Sep 09;9:328
pubmed: 19740421
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
Nurse Educ Today. 1991 Dec;11(6):461-6
pubmed: 1775125
Am J Bioeth. 2007 Nov;7(11):5-10
pubmed: 18027287
Intern Med J. 2012 May;42(5):491-6
pubmed: 22151101
Int J Nurs Stud. 2010 Nov;47(11):1451-8
pubmed: 20598692
JAMA. 2016 Jul 12;316(2):171-81
pubmed: 27404185
J Community Health. 2015 Feb;40(1):20-6
pubmed: 24878614
AIDS Educ Prev. 2014 Feb;26(1):81-93
pubmed: 24450280

Auteurs

Martin Duracinsky (M)

Université Paris-Diderot & Inserm, UMR1123, Patient-Centered Outcomes Research, Paris, France.
Hôpital Bicêtre, Service d'infectiologie, Le Kremlin Bicêtre, France.
AP-HP, hôpital Hôtel-Dieu, Unité de Recherche Clinique en Economie de la Santé (URC-ECO), Paris, France.

Frédérique Thonon (F)

Université Paris-Diderot & Inserm, UMR1123, Patient-Centered Outcomes Research, Paris, France.

Sonia Bun (S)

Université Paris-Diderot & Inserm, UMR1123, Patient-Centered Outcomes Research, Paris, France.

Imène Ben Nasr (I)

Université Paris-Diderot & Inserm, UMR1123, Patient-Centered Outcomes Research, Paris, France.

Aïchata Fofana Dara (AF)

Université Paris-Diderot & Inserm, UMR1123, Patient-Centered Outcomes Research, Paris, France.

Sabrina Lakhdari (S)

Université Paris-Diderot & Inserm, UMR1123, Patient-Centered Outcomes Research, Paris, France.

Laurence Coblentz-Baumann (L)

Université Paris-Diderot & Inserm, UMR1123, Patient-Centered Outcomes Research, Paris, France.

France Lert (F)

Agence nationale de recherche sur le sida et les hépatites virales (ANRS), Paris, France.

Svetlane Dimi (S)

Hôpital Foch, Service d'Hépatologie, Suresnes, France.

Olivier Chassany (O)

Université Paris-Diderot & Inserm, UMR1123, Patient-Centered Outcomes Research, Paris, France.
AP-HP, hôpital Hôtel-Dieu, Unité de Recherche Clinique en Economie de la Santé (URC-ECO), Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH